Medicinal plants are in rich source of antimicrobial agents. The present study was carriedout to evaluate the antimicrobial effect of plants from the same species as Brassica oleceraceanamely, white cabbage and red cabbage. The preliminary phytochemical analysis was tested byusing a different extract of these plants for the presence of various secondary metabolites likealkaloids, flavonoids, tannins, saponins, terpenoids, glycosides, steroids, carbohydrates, and aminoacids. The in vitro antimicrobial activity was screened against clinical isolates viz gram positivebacteria Staphylococcus aureus, Streptococcus pyogenes, gram negative bacteria Escherichia coli,Pseudomonas aeruginosa. Extracts found significant inhibition against all the pathogens.
In India, in ancient times, people used plant materials to make drug polyherbal formulations. Herbal drugs have enormous therapeutic potential which can be explored through various beneficial drug delivery systems and novel drug delivery systems. Great advancement has been made in the uses of plant therapeutics on the development of novel herbal formulations like polymeric nanoparticles, nanocapsules, liposomes, phytosomes, nanoemulsions, microsphere, transferosomes, and ethosomes. These formulations have reported having various advantages over the traditional formulations such as improved solubility and bioavailability, reduced toxicity, controlled drug delivery, protections of plant actives from degradation. Also, having the drug targeting properties with improved selectivity, drug delivery, and effectiveness with dose reduction not only increases the safety but also patient compliance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.